2019年冠状病毒病大流行期间美国医院抗生素使用趋势
Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.
作者信息
Rose Ashley N, Baggs James, Wolford Hannah, Neuhauser Melinda M, Srinivasan Arjun, Gundlapalli Adi V, Reddy Sujan, Kompaniyets Lyudmyla, Pennington Audrey F, Grigg Cheri, Kabbani Sarah
机构信息
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
出版信息
Open Forum Infect Dis. 2021 Jun 3;8(6):ofab236. doi: 10.1093/ofid/ofab236. eCollection 2021 Jun.
Abstract
We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. Although total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.
摘要
我们描述了2019冠状病毒病（COVID-19）住院患者的抗生素使用情况。大多数COVID-19住院患者接受了抗生素治疗。我们还按医院COVID-19负担分层，描述了2020年与2019年相比全院范围的抗生素使用情况。尽管年间抗生素总使用量有所下降，但某些抗生素的使用随着COVID-19负担的加重而增加。
相似文献
1
Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.2019年冠状病毒病大流行期间美国医院抗生素使用趋势
Open Forum Infect Dis. 2021 Jun 3;8(6):ofab236. doi: 10.1093/ofid/ofab236. eCollection 2021 Jun.
2
Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities.新冠疫情期间纽约市一家医院的抗菌药物管理视角：挑战与机遇。
Am J Health Syst Pharm. 2021 Mar 31;78(8):743-750. doi: 10.1093/ajhp/zxaa419.
3
Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).抗菌药物管理计划：在全球 2019 冠状病毒病（COVID-19）大流行期间，医院的重要资源。
Int J Antimicrob Agents. 2020 Nov;56(5):106145. doi: 10.1016/j.ijantimicag.2020.106145. Epub 2020 Aug 27.
4
A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).一项针对确诊和疑似 2019 年冠状病毒病（COVID-19）住院患者的抗生素处方评估的时点患病率调查。
J Glob Antimicrob Resist. 2021 Mar;24:45-47. doi: 10.1016/j.jgar.2020.11.025. Epub 2020 Dec 8.
5
Trends in antibiotic use before and during the coronavirus disease 2019 (COVID-19) pandemic across an integrated health system with different antimicrobial stewardship program models trends in antibiotic use by ASP model.2019年冠状病毒病（COVID-19）大流行之前及期间，不同抗菌药物管理项目模式的综合卫生系统中抗生素使用趋势：按抗菌药物管理项目模式划分的抗生素使用趋势
Antimicrob Steward Healthc Epidemiol. 2022 Apr 8;2(1):e55. doi: 10.1017/ash.2022.39. eCollection 2022.
6
Analysis of Changes in Antibiotic Use Patterns in Korean Hospitals during the COVID-19 Pandemic.新冠疫情期间韩国医院抗生素使用模式变化分析
Antibiotics (Basel). 2023 Jan 18;12(2):198. doi: 10.3390/antibiotics12020198.
7
Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore.新型冠状病毒肺炎（COVID-19）大流行对新加坡一家 tertiary 医院抗菌药物的使用和处方的影响。
Antimicrob Resist Infect Control. 2021 Feb 3;10(1):28. doi: 10.1186/s13756-021-00898-8.
8
Antibiotic stewardship in UK surgical departments: challenges and possible solutions.英国外科部门的抗生素管理：挑战与可能的解决方案。
Br J Hosp Med (Lond). 2021 Mar 2;82(3):1-6. doi: 10.12968/hmed.2020.0692. Epub 2021 Mar 13.
9
The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid).2019冠状病毒病大流行期间艰难梭菌感染的负担：意大利医院的一项回顾性病例对照研究（CloVid）
J Clin Med. 2020 Nov 27;9(12):3855. doi: 10.3390/jcm9123855.
10
Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.在荷兰的一项多中心回顾性队列研究中，COVID-19 住院患者早期的细菌合并感染较少，但经验性抗生素使用频繁。
Infect Dis (Lond). 2021 Feb;53(2):102-110. doi: 10.1080/23744235.2020.1839672. Epub 2020 Oct 24.
引用本文的文献
1
Impact of the COVID-19 Pandemic on Hospital Antimicrobial Purchasing in Canada (2018-2021): An Exploratory Analysis.2018 - 2021年新冠疫情对加拿大医院抗菌药物采购的影响：一项探索性分析
J Assoc Med Microbiol Infect Dis Can. 2025 May 29;10(2):146-159. doi: 10.3138/jammi-2024-0017. eCollection 2025 Jun.
2
Impact of the COVID-19 pandemic on the consumption of antibiotics and the emergence of AMR: case study in a general hospital.新冠疫情对抗生素使用及抗菌药物耐药性产生的影响：一家综合医院的案例研究
Front Public Health. 2025 Jun 23;13:1584574. doi: 10.3389/fpubh.2025.1584574. eCollection 2025.
3
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.COVID-19患者使用经验性阿奇霉素会影响呼吸道微生物组和抗菌药物耐药组，且无抗炎益处。
Res Sq. 2025 Jun 20:rs.3.rs-6875205. doi: 10.21203/rs.3.rs-6875205/v1.
4
Trends in inpatient antibiotic use in Indonesia and the Philippines during the COVID-19 pandemic.新冠疫情期间印度尼西亚和菲律宾住院患者抗生素使用趋势。
Antimicrob Steward Healthc Epidemiol. 2025 Jun 25;5(1):e134. doi: 10.1017/ash.2025.48. eCollection 2025.
5
A Retrospective Study of the Impact of the COVID-19 Pandemic on the Utilization and Quality of Antibiotic Use in a Tertiary Care Teaching Hospital in Low-Resource Settings.一项关于新冠疫情对资源匮乏地区三级护理教学医院抗生素使用情况及质量影响的回顾性研究
Antibiotics (Basel). 2025 May 23;14(6):535. doi: 10.3390/antibiotics14060535.
6
Antimicrobial use before and during COVID-19: data from 108 Veterans Affairs medical centers.COVID-19疫情之前及期间的抗菌药物使用情况：来自108家退伍军人事务医疗中心的数据
Antimicrob Steward Healthc Epidemiol. 2024 Aug 7;4(1):e109. doi: 10.1017/ash.2024.352. eCollection 2024.
7
Antimicrobial Use among Adult Inpatients in Northern Canada, 2019-2021.2019 - 2021年加拿大北部成年住院患者的抗菌药物使用情况
Can J Hosp Pharm. 2024 Dec 11;77(4):e3595. doi: 10.4212/cjhp.3595. eCollection 2024.
8
A quasi-experimental analysis comparing antimicrobial usage on COVID-19 and non-COVID-19 wards.一项比较新冠病房和非新冠病房抗菌药物使用情况的准实验分析。
Antimicrob Steward Healthc Epidemiol. 2024 Oct 31;4(1):e192. doi: 10.1017/ash.2024.417. eCollection 2024.
9
Evaluating Antibiotic Treatment Guideline Adherence to Ongoing Antibiotic Stewardship in a Tertiary Care Setting: A Retrospective Observational Study.在三级医疗环境中评估抗生素治疗指南对持续抗生素管理的依从性：一项回顾性观察研究。
Can J Infect Dis Med Microbiol. 2024 Apr 17;2024:6663119. doi: 10.1155/2024/6663119. eCollection 2024.
10
Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry.COVID-19 患者早期经验性使用抗生素：来自国际 VIRUS 登记处的结果。
Int J Infect Dis. 2024 Mar;140:39-48. doi: 10.1016/j.ijid.2023.12.006. Epub 2023 Dec 19.
本文引用的文献
1
Risk of Clinical Severity by Age and Race/Ethnicity Among Adults Hospitalized for COVID-19-United States, March-September 2020.2020年3月至9月美国因新冠肺炎住院的成年人中按年龄和种族/族裔划分的临床严重程度风险
Open Forum Infect Dis. 2020 Dec 28;8(2):ofaa638. doi: 10.1093/ofid/ofaa638. eCollection 2021 Feb.
2
Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study.COVID-19患者入院时合并感染的患病率：一项多中心研究
Open Forum Infect Dis. 2020 Dec 21;8(1):ofaa578. doi: 10.1093/ofid/ofaa578. eCollection 2021 Jan.
3
Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations.美国住院患者 COVID-19 诊断代码的使用率和准确性。
JAMA. 2020 Dec 22;324(24):2553-2554. doi: 10.1001/jama.2020.20323.
4
The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations.新冠疫情期间持续开展抗菌药物管理的必要性及可行建议
Antibiotics (Basel). 2020 Dec 14;9(12):904. doi: 10.3390/antibiotics9120904.
5
Electronically Available Patient Claims Data Improve Models for Comparing Antibiotic Use Across Hospitals: Results From 576 US Facilities.电子可用患者索赔数据可改善医院间抗生素使用比较模型：来自 576 家美国医疗机构的结果。
Clin Infect Dis. 2021 Dec 6;73(11):e4484-e4492. doi: 10.1093/cid/ciaa1127.
6
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.COVID-19 患者的细菌合并感染和继发感染：一项实时快速综述和荟萃分析。
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
7
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染：英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
8
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
9
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体：一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
10
Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deck.让抗菌药物管理计划参与到应对新冠疫情的工作中：全员出动。
Infect Control Hosp Epidemiol. 2020 Jun;41(6):744-745. doi: 10.1017/ice.2020.69.
Zotero 插件